Please login to the form below

I have forgotten my password

Novavax plans to meet US COVID-19 vaccine demand in 2021

Company plans to produce two billion doses if vaccine proves effective

Seres’ microbiome-based therapy hits the mark in phase 3

Drug reduced C.difficile infection recurrence

Roche scores FDA approval for SMA drug risdiplam, now named Evrysdi

Drug poised to challenge rivals Spinraza and Zolgensma

Eli Lilly, Innovent showcase Tyvyt data in first-line NSCLC

Detailed phase 3 results presented at the virtual World Conference on Lung Cancer

Biogen’s highly-anticipated Alzheimer’s drug wins FDA fast-track

Drug could become first treatment to reduce clinical decline in Alzheimer's

Porterhouse Medical Group joins imc group

Agency will be a key addition to imc's growing network of international offices

Bristol-Myers Squibb’s revenues rise on Celgene acquisition

Sales of immunotherapy Opdivo decreased due to COVID-19 impact

Tecentriq combo fails in advanced triple negative breast cancer

Tecentriq plus paclitaxel failed to improve progression-free survival

Biogen pays Denali $1bn upfront for Parkinson’s disease programme

Deal includes portfolio of small molecule LRRK2 inhibitors

Q&A: Kate Callan

Q&A: Kay Wesley

PME chats to the Chief Executive of Kanga Health Ltd and Town Councillor at Women’s Equality Party Congleton
Q&A: Elizabeth Egan

Elizabeth Egan is President of Havas Lynx Group

Novartis builds its case for novel MS treatment ofatumumab

Detailed results from phase 3 studies published in NEJM
J&J inks $1bn deal with US for coronavirus vaccine

Agreement includes manufacturing and delivery of 100 million doses
Pfizer’s Xalkori follow-up Lorbrena hits the mark in first-line lung cancer

ALK inhibitor improved progression-free survival in first-line setting
AbbVie exits Voyager alliance for Alzheimer’s/Parkinson’s gene therapies

Biotech company did not disclose the reason for the partnership's end
Merck enters agreement with Hanmi for investigational NASH drug

Licensing agreement includes $10m upfront payment
Novavax reports promising phase 1 results for coronavirus vaccine

Candidate induced immune response in early-stage clinical trial
AbbVie, Amgen and Takeda team up for joint COVID-19 trial

Collaborative trial will evaluate three anti-inflammatory drugs

Latest appointments

Ex-J&J exec Denice Torres joins bluebird bio’s board

Torres brings over 25 years of executive management experience to the role
New hires at EMA, Gilead and BeiGene

EMA gains a new executive director, Gilead appoints a new senior vice president and BeiGene hires a new chief business exec
New faces at HCA, P\S\L Group and Health Unlimited

New board structure announced at HCA and a new MD appointed at Health Unlimited
W2O taps Tom Richards as creative leader of 21GRAMS

Richards joins as co-global chief creative officer
McCann Health London bolsters creative leadership team

Guy Swimer and Kieran Delaney will lead the team

More appointments

Communiqué Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company

Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

Can involving patients in design transform the clinical trial experience?: While the research space is a heavily regulated environment and there are rules that we must abide by, this doesn’t mean clinical study materials have to be ‘boring’ or the...
Planning your clinical trial? Why you need to engage patients sooner: It’s highly likely that clinical studies are deterring patients based on decisions made in the early stages, such as during planning and design....
Patient-centricity in improving patient recruitment advertising: This blog looks into the importance of concepts and patient centricity in patient recruitment....

Quick links

Infographics

Multimedia

<>